Heart Transport Systems Market, by Disease Indication (Heart failure, Cardiomyopathy, Congenital Heart Defect, Coronary Heart Disease and Others), by End User (Hospitals, Cardiac Centers, and Research Centers), and by Geography (North America, Asia Pacific, Europe, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

Heart transport systems are devices used for maintenance and nourishment of heart while it is being transported from harvest in preparation for transplantation. Heart transportation is a highly critical process as the heart can only be preserved for around 4 hours in an ice box. Advanced transport systems such as LifeCradle product developed by Organ Transport Systems can preserve heart for 12 hours.

The Global Heart Transport System – Market Dynamics

Increasing prevalence of cardiovascular diseases that often require heart transplant surgeries and government initiatives in funding for research and development in heart transplant surgeries are major factors driving growth of the global heart transport systems market. According to The International Society for Heart and Lung Transplantation, in 2014, around 586 heart transplant surgeries were performed worldwide.

* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/2405

Increasing stress among the populace along with sedentary work, high fat intake, and congenital defects in heart also increase demand for heart transplant. This in turn boosts growth of the global heart transport systems market.

The Global Heart Transport Systems Market – Regional Insights

North America accounted for the largest share in the global heart transport systems market in 2017, owing to increasing number of people diagnosed with coronary artery disease, heart failure, and cardiomyopathy. According to the U.S. Pediatric Cardiomyopathy Registry, the annual incidence of cardiomyopathy in the U.S. was around 1.13 per 10, 00,000 children younger than 18 years of age. Europe accounted for the second largest share in the market in terms of revenue, owing to increasing research and development activities in heart transport systems. . Market in Asia Pacific is expected to witness the fastest growth, owing to increasing geriatric population in the region increases prevalence of cardiovascular disease. For instance, according to a report published by Asia Pacific Journal, in 2018, 7 out of 10 deaths are expected to cause due to cardiovascular diseases by 2020.

Browse Research Report: https://www.coherentmarketinsights.com/ongoing-insight/heart-transport-systems-market-2405

The Global Heart Transport System – Competitive Landscape

Major players operating in the global heart transport systems market include, Paragonix Technologies, Inc., Organ Transport Systems, Pulse Heart Transportation System, and others. Key players in the market are focused on launching new heart transport systems in order to enhance their market share. For instance, in December 2018, Paragonix Technologies received approval from the U.S. Food and Drug Administration (FDA) for its Paragonix Sherp, a cardiac transport system.

Buy-Now this research report: https://www.coherentmarketinsights.com/insight/buy-now/2405

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Contact Us:
mailto:[email protected]
U.S. Office:
Name: Mr. Shah
Coherent Market Insights 1001 4th Ave,
# 3200 Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN : +050-5539-1737